NCT06761924 Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
| NCT ID | NCT06761924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beni-Suef University |
| Condition | Patient Satisfaction |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2025-02 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2025-02 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to fill the knowledge gap by investigating the predictors of success for TPVB in patients with herpetic neuralgia. By identifying demographic, clinical, previous medications and procedural factors associated with positive outcomes, this research seeks to enhance the efficacy of TPVB and improve pain management strategies for patients suffering from herpetic neuralgia.
Eligibility Criteria
Inclusion Criteria: * Adults aged from18 to 70 years * Diagnosed with herpetic neuralgia. * Able and willing to provide informed consent. * ASA I - II * One dermatomal affection * Thoracic distribution Exclusion Criteria: * Contraindications to TPVB as ( Infection at site of injection, empyema , coagulopathy and neoplastic lesion occupying the paravertebral space) * Known allergies to study medications (bupivacaine, Dexamethasone). * Severe comorbidities that could interfere with study participation.
Contact & Investigator
Dina M Fakhry, MD
PRINCIPAL INVESTIGATOR
Beni-Suef University
Frequently Asked Questions
Who can join the NCT06761924 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Patient Satisfaction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06761924 currently recruiting?
Yes, NCT06761924 is actively recruiting participants. Contact the research team at drdina.mahmoud@med.bsu.edu.eg for enrollment information.
Where is the NCT06761924 trial being conducted?
This trial is being conducted at Banī Suwayf, Egypt.
Who is sponsoring the NCT06761924 clinical trial?
NCT06761924 is sponsored by Beni-Suef University. The principal investigator is Dina M Fakhry, MD at Beni-Suef University. The trial plans to enroll 140 participants.